Cofco Biotechnology (000930.SZ): The project with an annual production capacity of 30,000 tons of lactide will begin trial production this month.

Cofco Biotechnology (000930.SZ) announced that the company had previously invested in and constructed a project with an annual production capacity of 30,000 tons of lactide. As of the date of this announcement, the project has completed main construction, installation of core equipment, and linked commissioning. The facility is operating smoothly and will begin trial production this month, with capacity ramp-up to be advanced gradually. Once the project reaches full capacity, it will further enrich the company's portfolio of bio-based biodegradable materials. By fully leveraging the company's existing reserved land and complete utility support facilities, it will harness industrial cluster synergies, optimize the company's business structure, and expand profit growth drivers, in line with the company's long-term development strategy. As of the date of this announcement, the project is at the stage of initiating trial production and has not yet formed large-scale sales. It is not expected to have a material impact on the company's financial condition or operating results for 2026.